Picton Mahoney Asset Management Harmony Biosciences Holdings, Inc. Transaction History
Picton Mahoney Asset Management
- $4.9 Billion
- Q4 2024
A detailed history of Picton Mahoney Asset Management transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Picton Mahoney Asset Management holds 30 shares of HRMY stock, worth $995. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30Holding current value
$995% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
257Shares Held
46.7MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$220 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$194 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$157 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$75.7 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$52.5 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.96B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...